Skip to main content
. Author manuscript; available in PMC: 2013 Sep 4.
Published in final edited form as: Biol Blood Marrow Transplant. 2011 Aug 26;18(5):690–697. doi: 10.1016/j.bbmt.2011.08.017

Table 1.

Overall Outcomes of CD34-enrichment Procedures

N=84 %CD34
Recovery
%CD34
Purity
Log TCD % Viability
Mean 66.1 93.0 4.8 96.6
SD ±20.3 ±8.3 ±0.6 ±3.8
Median 65.0 96.7 4.9 97.7
Min 29.9 61.5 3.2 74.0
Max 125.6 99.8 5.9 100.0

CD34+ cell recovery and Log TCDare calculated based on the starting apheresis product and the product as recovered from the tubing set. Viability was assessed by 7-AAD staining.